ASTS
AST SpaceMobile, Inc.
ASTS has the edge over MYPS overall, supported by stronger fundamentals and stronger modeled upside.
MYPS
PLAYSTUDIOS, Inc.
MYPS has lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MYPS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Stable | |
| Strong |
MYPS's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
MYPS PE Valuation
MYPS has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MYPS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect MYPS's profitability to weaken, with its earnings and revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over MYPS on earnings, with more consistent year-over-year improvement.
MYPS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.92 | -$1.02 |
| Q2 2026 | -$3.70 | -$1.30 |
| Q1 2026 | -$2.90 | -$0.50 |
| Q4 2025 | -$2.30 | -$0.10 |
| Q3 2025 | -$2.90 | -$1.00 |
| Q2 2025 | -$2.40 | -$1.00 |
| Q1 2025 | -$2.40 | -$1.10 |
| Q4 2024 | -$2.20 | -$0.70 |
MYPS lost $3.92 per share over the past year, a bigger loss than the year before.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over MYPS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
MYPS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $48.9M | -15% |
| Q2 2026 | $55M | -7.3% |
| Q1 2026 | $58.4M | -6.9% |
| Q4 2025 | $55.4M | -18% |
| Q3 2025 | $57.6M | -19% |
| Q2 2025 | $59.3M | -18% |
| Q1 2025 | $62.7M | -19% |
| Q4 2024 | $67.8M | -12% |
MYPS's revenue has slid since its 2023 peak: $49M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -40% | -27 points |
| Q2 2026 | -17% | -12 points |
| Q1 2026 | -23% | -18 points |
| Q4 2025 | -18% | +15 points |
| Q3 2025 | -14% | -6.9 points |
| Q2 2025 | -5.9% | -0.4 points |
| Q1 2025 | -4.4% | -2.2 points |
| Q4 2024 | -33% | -30 points |
MYPS has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
MYPS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.6M | +42% |
| Q2 2026 | $5.4M | -59% |
| Q1 2026 | $3.7M | +15% |
| Q4 2025 | $3.6M | -69% |
| Q3 2025 | $5.4M | -62% |
| Q2 2025 | $13.2M | +3.4% |
| Q1 2025 | $3.2M | -10% |
| Q4 2024 | $11.5M | -19% |
MYPS has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
MYPS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.6% | -718K shares |
| 1 year | -4.2% | -526K shares |
| 3 years | -20% | -2.9M shares |
| 5 years | -13% | -1.8M shares |
| Available history | -53% | -13.5M shares |
MYPS has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.2M |
| Q2 2026 | $1.6M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $49,000 |
| Q2 2025 | $1.9M |
| Q1 2025 | $1.6M |
| Q4 2024 | $2M |
MYPS spent $6M buying back its own shares over the past year, up 4.5% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MYPS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -25.2x | Net Cash |
| Q4 2025 | -7.3x | Net Cash |
| Q3 2025 | -36.8x | Net Cash |
| Q2 2025 | -14.2x | Net Cash |
| Q1 2025 | -11.0x | Net Cash |
| Q4 2024 | -8.6x | Net Cash |
| Q3 2024 | -3.2x | Net Cash |
| Q2 2024 | -3.1x | Net Cash |
MYPS has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
MYPS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.0 | Neutral |
| Stochastic | 29.3 | Neutral |
MYPS's weekly RSI is 47 (neutral) and its Stochastic is 29 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
MYPS PE vs Technology Sector
| Metric | MYPS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MYPS has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
MYPS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.45 | 8.1% above |
| 20 week MA | $5.36 | 10% below |
| 50 week MA | $5.39 | 11% below |
| 100 week MA | $9.16 | 47% below |
| 200 week MA | $19.1 | 75% below |
MYPS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 75% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
MYPS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $100.5 | $100.5 | 0% |
| 2021 | $100.5 | $41.8 | -58% |
| 2022 | $41.8 | $37.7 | -9.8% |
| 2023 | $37.7 | $27.1 | -28% |
| 2024 | $27.1 | $19.1 | -30% |
| 2025 | $19.1 | $6.76 | -65% |
| 2026 YTD | $6.76 | $4.81 | -29% |
MYPS has the edge over ASTS on returns for 2026, with the stronger performance.